BioHarvest Sciences Inc.

Recent News

• BioHarvest Sciences CEO to Detail Multi-Pronged Cannabis Strategy in North America at Online Webinar, Nov 16 at 2pm ET

  Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - November 14, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") announces that CEO Ilan Sobel will host an online investor presentation on Wednesday, November 16. Following the October 25th breakthrough achievement and other important recent developments at BHSC and in the Cannabis market, the Company invites all interested investors and media to register for this event, where Ilan Sobel will share updated details on the...

  2022-11-14 1:59 PM EST
• BioHarvest Introduces its 1st Cannabis Breakthrough Composition with Major Medical and Commercial Implications

  BioHarvest demonstrates unprecedented Cannabinoids tuning and elicitation capabilities (12X increase versus original plant) using its proprietary Bio-Plant CELLicitation™ platform technologyContains high amounts of minor Cannabinoids such as THCV (2.5%) and CBDV (4.4%) providing unique medical and commercial benefitsThe Company plans to reveal additional information related to its high THC Cannabis product line by year end Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - October 25, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company")...

  2022-10-25 8:05 AM EDT
• BioHarvest Sciences Inc. Announces Closing of the First Tranche of Private Placement of Convertible Notes

  Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - October 13, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that it has closed the first tranche (the "First Tranche") of its non-brokered private placement of convertible notes (the "Notes") previously announced on April 7, 2022 and October 7, 2022. Under the First Tranche, the Company has issued Notes in the aggregate principal amount of $6,878,243.65 CAD.In connection with the First...

  2022-10-13 7:30 AM EDT
• BioHarvest Sciences Inc. Announces the Oversubscription of Private Placement of Convertible Notes and Change in Note Terms.

  Vancouver, British Columbia, and Rehovot, Israel--(Newsfile Corp. - October 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or the "Company") is pleased to announce that its non-brokered private placement of convertible notes (the "Notes") previously announced of up to $6,300,000 CAD has been oversubscribed and has now been increased to up to $10,000,000 CAD in order to further accelerate VINIA® sales growth and Cannabis commercialization activities in North America. The Company also announces the interest rate...

  2022-10-07 7:30 AM EDT
• BioHarvest Sciences Inc. Reports Record Sales Results in Q3 2022 with Strong Momentum Building on All Fronts

  VINIA® sales orders reached a record high of USD 1.71M representing 145% growth compared to Q3 2021 and 81% growth compared to Q2 2022Q3 Sales in the US delivered 3X the sales of Q2 2022 and crossed the USD 1 Million mark Strong sales momentum and increase in subscribers support guidance to achieve USD 5M-7M sales orders in in 2022, and cash flow positive in 2023Unique Cannabis composition (analysis performed by independent 3rd party certified laboratory) will be announced on...

  2022-10-03 7:30 AM EDT
• Business Intelligence Group Awards BioHarvest Sciences with the Prestigious Sustainability Leadership Award

  The award recognizes the sustainability impact of BioHarvest's Bio Plant CELLicitation technology, which enables industrial production of plant metabolites without growing the plant itself BioHarvest Sciences receives the award with other industry thought leaders such as AstraZeneca, Agilent, and Honeywell F

  2022-09-06 7:30 AM EDT
• BioHarvest Sciences Inc. Launches First Major United States Marketing Campaign

  Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - August 18, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") has announced the first multimedia campaign for VINIA™ in the USA, Phase 1. The company is scaling up its US marketing in line with a 2022 growth plan that aims for significant growth in sales orders following commercial entry in 2021."We are delighted to launch our first integrated marketing campaign aimed at...

  2022-08-18 7:30 AM EDT
• BioHarvest Sciences Inc. Commences Trading on the OTCQB Market

  Vancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 18, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTCQB: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") ") is pleased to announce that its common shares are now trading on the OTCQB® Venture Market under the ticker symbol "CNVCF"."Admission to the OTCQB® market is an important step to increase US investor access to BioHarvest Sciences, and it provides US investors an additional level of transparency as we expand both our...

  2022-07-18 7:30 AM EDT
• BioHarvest Sciences Inc. Receives the Largest Ever VINIA Purchase Order from BATORY Foods

  Purchase order of 1,000 kg for prompt delivery to support the growing demand for VINIA®Pipeline of 6 major customers testing VINIA® for inclusion in their final productsFavorable terms of Purchase Order reflect the increasing value of the product and substantially contribute to BioHarvest's top lineVancouver, British Columbia and Rehovot, Israel--(Newsfile Corp. - July 7, 2022) - BioHarvest Sciences Inc. (CSE: BHSC) (OTC PINK: CNVCF) (FSE: 8MV) ("BioHarvest" or "the Company") today announced that Batory Foods (Batory) has placed a...

  2022-07-07 7:30 AM EDT
• BioHarvest Sciences Inc. Reports Strong Q2 2022 Results with Major Achievements on All Fronts

  VINIA® sales orders reached a record high of USD 947k representing 99% growth compared to Q2 2021 and 24% growth compared to Q1 2022BioHarvest reiterates guidance for year-on-year sales orders growth of 2.5-3.5X to reach USD 5M - 7MStarted production of VINIA® at new 20 tons/year facility enabling the scaling of VINIA® sales and conversion of current 2 tons/year facility to CannabisApplied for the Cannabis production license in IsraelUnveiled the profile of its unique Cannabis composition triggering serious partnership discussions...

  2022-07-05 7:30 AM EDT